首页> 外文期刊>Laboratory news >Investment in antibacterial research 'inadequate'
【24h】

Investment in antibacterial research 'inadequate'

机译:抗菌研究投资“不足”

获取原文
获取原文并翻译 | 示例
           

摘要

Less than 1% of public and charitable funding from bodies in the UK was awarded to antibiotics research in the last five years. Researchers at the University of Birmingham found that of the £13.8 billion research funding available, only £95 million, or 0.7% of the total, was awarded to research on antibiotics. "The message that antibacterial (i.e., antibiotic) drug resistance has become a world health crisis has been brought to global attention by WHO, the European Union, the World Economic Forum and, most recently, the UK Chief Medical Officer," said Professor Laura Piddock. "As a world leader in biomedical research, UK research has an important part to play in tackling this crisis. However, our study clearly shows that the proportion of public and charitable funding for research into new antibiotics, understanding resistance mechanisms and ways of tackling resistance are inadequate for the size of the task."
机译:在过去的五年中,来自英国机构的公共和慈善资金不到1%被授予了抗生素研究领域。伯明翰大学的研究人员发现,在可用的138亿英镑研究资金中,只有9500万英镑(占总额的0.7%)用于抗生素研究。劳拉教授说:“世界卫生组织,欧盟,世界经济论坛以及最近的英国首席医疗官已经引起了人们对抗菌(即抗生素)耐药性已成为世界卫生危机的信息的关注。”皮多克。 “作为生物医学研究的全球领导者,英国的研究在应对这一危机方面发挥着重要作用。但是,我们的研究清楚地表明,用于新抗生素研究,了解抗药性机制和抗药性方法的公共和慈善资金比例不足以完成任务的大小。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号